Cold Atmospheric Plasma Triggers Apoptosis via the Unfolded Protein Response in Melanoma Cells

Simple Summary The development of novel therapies for cancer treatment is the key to improve patient prognosis. Cold atmospheric plasma (CAP) is a promising technology to treat all kinds of cancers, but the exact mechanisms of its action have not yet been identified. This study aimed to understand the effects of CAP treatment on melanoma cells to contribute to its potential use in tumor therapy. We identified a strong activation of the unfolded protein response along with a reduction in intracellular ceramide levels, which were linked to each other and to CAP-induced cell death. Furthermore, we showed that pharmacological reduction in ceramides strengthens the effects of CAP treatment in melanoma cells. Cold atmospheric plasma (CAP) describes a partially ionized gas carrying large amounts of reactive oxygen (ROS) and nitrogen species (RNS). Numerous studies reported strong antitumor activity of CAP, thus rendering it a promising approach for tumor therapy. Although several cellular mechanisms of its cytotoxicity were identified in recent years, the exact molecular effects and contributing signaling pathways are yet to be discovered. We discovered a strong activation of unfolded protein response (UPR) after CAP treatment with increased C/EBP homologous protein (CHOP) expression, which was mainly caused by protein misfolding and calcium loss in the endoplasmic reticulum. In addition, both ceramide level and ceramide metabolism were reduced after CAP treatment, which was then linked to the UPR activation. Pharmacological inhibition of ceramide metabolism resulted in sensitization of melanoma cells for CAP both in vitro and ex vivo. This study identified a novel mechanism of CAP-induced apoptosis in melanoma cells and thereby contributes to its potential application in tumor therapy.

Automated summary

The exact mechanisms of action of cold atmospheric plasma (CAP) treatment for cancer are still unclear. This study found that CAP treatment caused a reduction in intracellular ceramide levels and a strong activation of the unfolded protein response (UPR) in melanoma cells. Additionally, pharmacological reduction in ceramides enhanced the effects of CAP treatment.